Sometimes change can be difficult. In the case of OncoMethylome Sciences, which saw itself transform from a research firm to MDxHealth (Liege, Belgium) a company that develops and commercializes cancer assessment tests, the change was not only an easy one, but necessary for the viability of the firm. (Medical Device Daily)

Exact Sciences (Madison, Wisconsin) said that it has completed its previously reported underwritten public offering of common stock at a price of $6 per share. (Medical Device Daily)

After more than four years of preparation and planning, Atrium Medical (Hudson, New Hampshire) reported that it has enrolled its final patient in the iCast Atrium Registry Ultrasound Study (iCARUS). (Medical Device Daily)